Theravance Biopharma

TBPHNasdaq Cayman Islands Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$872.792 M

$16.93 +0.06%

Close of 7 Aug 2026

Revenue

$107.5M

#2492 by revenue

Earnings

$105.9M

#1291 by earnings

Shares outstanding

51,553,005

Latest filing cover page

P/E ratio

8.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#171AnnexonANNX$886.4M
#172Design TherapeuticsDSGN$875.5M
#173Theravance BiopharmaTBPH$872.8M
#174Kura OncologyKURA$849.6M
#175Aclaris TherapeuticsACRS$825.4M

Where these numbers come from

Share counts and financials for Theravance Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.